RobertABonomoMD
Infectious Disease • Cleveland, OHProfessor, Medicine, Case Western Reserve University School of Medicine
Dr. Bonomo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10701 East Blvd
Id Section, Va Hospital
Cleveland, OH 44106Phone+1 216-791-3800
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1990 - 1994- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1983 - 1984
Case Western Reserve University School of MedicineClass of 1983
Certifications & Licensure
OH State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Multi-Drug Resistant Organism Network Start of enrollment: 2016 Jun 16
Publications & Presentations
PubMed
- 22 citationsReduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2 β-LactamaseYohei Doi, David L. Paterson, Jennifer M. Adams-Haduch, Hanna E. Sidjabat, Alexandra O'Keefe
Antimicrobial Agents and Chemotherapy. 2009-07-01 - 45 citationsCharacterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adeq...Markus Hilty, Parham Sendi, Salome Nadja Seiffert, Sara Droz, Vincent Perreten
International Journal of Antimicrobial Agents. 2013-03-01 - 138 citationsA Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.Pranita D. Tamma, Yohei Doi, Robert A. Bonomo, J. Kristie Johnson, Patricia J. Simner
Clinical Infectious Diseases. 2019-09-27
Journal Articles
- Ceftazidime/avibactam, Meropenem/vaborbactam or Both? Clinical and Formulary ConsiderationsRobert A Bonomo, Keith S Kaye, Clinical Infectious Diseases
- Empiric Therapy with Carbapenem-Sparing Regimens for Bloodstream Infections Due to Extended-Spectrum Β-lactamase–Producing Enterobacteriaceae: Results from the INCREME...Federico Perez, Robert A Bonomo, Clinical Infectious Diseases
Authored Content
- IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative InfectionsJune 2023
Press Mentions
Tainted Eye Drops Cause Dangerous Eye InfectionMay 11th, 2023- Almost 70 Infections Linked to Recalled Eyedrops in 16 States, CDC SaysApril 9th, 2023
- A New Way to Infiltrate (And Destroy) Some of the Deadliest Drug-Resistant BugsSeptember 16th, 2021
- Join now to see all
Grant Support
- A Mechanism-Based Approach To Metallo-Beta-Lactamase InhibitionNational Institute Of Allergy And Infectious Diseases2012
- Challenges In Beta-Lactamase Mediated ResistanceNational Institute Of Allergy And Infectious Diseases2010–2011
- Multidrug Resistant Acinetobacter Baumannii,National Institute Of Allergy And Infectious Diseases2007–2011
- Detecting Carbapenem And Quinolone Resistance In Klebsiella Pneumoniae Using Pcr/National Institute Of Allergy And Infectious Diseases2009–2010
- Understanding Ceftazidime Resistance In SHV B-LactamasesNational Institute Of Allergy And Infectious Diseases2005–2009
- Mechanisms Of Antibiotic Resistance In The Nursing HomeNational Institute On Aging1995–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
